A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately to Severely Active Ulcerative Colitis

Project: Research

Project Details

StatusActive
Effective start/end date7/03/236/03/28